DAL-1 was evaluated as a candidate for lung cancer gene therapy since its expression is lost in various lung cancers, and overexpression significantly suppressed the proliferation and invasion and promoted cell apoptosis. The gene discussed is EPB41L3; the disease is lung cancer.